Entera Bio
ENTX
#9087
Rank
โ‚ฌ58.3 M
Marketcap
1,61ย โ‚ฌ
Share price
-1.71%
Change (1 day)
145.69%
Change (1 year)

P/E ratio for Entera Bio (ENTX)

P/E ratio as of November 2024 (TTM): -5.93

According to Entera Bio's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -5.93103. At the end of 2023 the company had a P/E ratio of -1.94.

P/E ratio history for Entera Bio from 2018 to 2024

PE ratio at the end of each year

Year P/E ratio Change
2023-1.9419.31%
2022-1.62-73.53%
2021-6.13273.23%
2020-1.64-28.72%
2019-2.30-0.52%
2018-2.32

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.